Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase

J Virol. 1996 Aug;70(8):5662-4. doi: 10.1128/JVI.70.8.5662-5664.1996.

Abstract

We monitored a subject newly infected with a zidovudine-resistant human immunodeficiency virus type 1 strain and found that in the absence of drug, the viral population with the resistance-conferring tyrosine (TAC) codon 215 of reverse transcriptase was gradually replaced. By using standard formulas to model the effects of selection at a single locus in an asexual haploid population, the relative fitness gain of the viral population with a single mutation at codon 215 creating a serine (TCC) was calculated. We concluded that a viral population with a serine at reverse transcriptase codon 215 conferring zidovudine sensitivity was between 0.4 and 2.3% more fit.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections / virology*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / enzymology
  • HIV-1 / genetics*
  • Humans
  • Mutation
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Zidovudine / pharmacology*

Substances

  • Reverse Transcriptase Inhibitors
  • Zidovudine
  • HIV Reverse Transcriptase